Cardiac Marker Testing Market Scope And Analysis

  • Report Code : TIPRE00022451
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Analyse de la dynamique et de la portée du marché des tests de marqueurs cardiaques d'ici 2025-2031

Buy Now

Cardiac Marker Testing Market Report Cardiac Marker Testing Market Size and Share Cardiac Marker Testing Market Scope and Analysis

Cardiac Marker Testing Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 9.1%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Type de produit
  • réactifs et kits
  • instruments
By Type de biomarqueur
  • troponine I et T
  • CK-MB
  • BNP
  • myoglobine
  • Hs-CRP
  • autres biomarqueurs
By Application
  • infarctus du myocarde
  • insuffisance cardiaque congestive
  • syndrome coronarien aigu
  • athérosclérose
  • ischémie
By Utilisateur final
  • tests en laboratoire
  • tests au point de service
  • autres
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Roche Diagnostics Ltd
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Danaher Corporation
  • Ortho Clinical Diagnostics
  • Randox laboratories Ltd.
  • bioMérieux SA
  • LSI Medience Corporation
  • DiaSorin S.p.A.